Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 26, 2026 02:00 ET | Source: Scancell Holdings Plc

Scancell announces FDA clearance of IND application for global Phase 3 trial of iSCIB1+ in advanced melanoma

Unlocks path towards registrational Phase 3 trial planned to start in 2026 Data from Phase 2 SCOPE trial show iSCIB1+ has potential to redefine standard of care (SoC) iSCIB1+ shows an interim...
January 26, 2026 01:00 ET | Source: AMG Critical Materials N.V.

AMG LIVA to Install Hybrid Energy Storage System Battery at Aramco Site

Amsterdam, 26 January 2026 --- AMG Critical Materials N.V. ("AMG", EURONEXT AMSTERDAM: "AMG") announces that its subsidiary, AMG LIVA, will install its industrial battery, namely the Hybrid Energy...
January 25, 2026 23:36 ET | Source: Vivani Medical, Inc.

Vivani Medical, Inc. Announces Pricing of Common Stock Offering

ALAMEDA, Calif., Jan. 25, 2026 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (Nasdaq: VANI) (“Vivani” or the “Company”), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting...
January 25, 2026 19:30 ET | Source: Faraday Future

Faraday Future Founder and Co-CEO YT Jia Shares Weekly Investor Update: The First FF EAI Robotics Product Has Completed U.S. Regulatory Certification and is About to Officially Begin Sales

Regulatory approvals for the remaining FF EAI Robotic products in the Company’s initial batch are advancing and are expected to be finalized soon.BlackRock increased its holdings in FFAI once again....
January 25, 2026 18:30 ET | Source: Biogen Inc.

FDA Accepts LEQEMBI® IQLIK™ (lecanemab-irmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer’s Disease under Priority Review

If approved, LEQEMBI IQLIK would be the first and only anti-amyloid treatment to offer at-home injection options for initiation and maintenance dosing for this progressive, relentless disease FDA...
January 25, 2026 17:30 ET | Source: AVITA Medical

Data at 2026 Boswick Burn & Wound Symposium highlight first integrated use of AVITA Medical technologies

Data at 2026 Boswick Burn & Wound Symposium highlight AVITA Medical technologies RECELL, PermeaDerm, and Cohealyx in acute wound care
January 25, 2026 17:00 ET | Source: Baker Hughes

Baker Hughes Announces Fourth-Quarter and Full-Year 2025 Results

Fourth-quarter highlights Orders of $7.9 billion, including $4.0 billion of IET orders.Record RPO of $35.9 billion, including record IET RPO of $32.4 billion.Revenue of $7.4 billion, flat...
January 23, 2026 18:05 ET | Source: Plaid Technologies Inc.

Plaid Technologies Launch Strategic Assessment of High-Performance Graphene Water-Shedding Coatings

VANCOUVER, British Columbia, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Plaid Technologies Inc. (CSE: STIF) (OTC: STIFF) (FRA: 5QX0) (“Plaid” or the “Company”) today announces the launch of a strategic...
January 23, 2026 17:30 ET | Source: Ninepoint Partners LP

Ninepoint Partners Announces January 2026 Cash Distributions for its ETFs and ETF Series Securities

TORONTO, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Ninepoint Partners LP (“Ninepoint Partners”) today announced the January 2026 cash distributions for its ETFs and ETF Series securities. The record date...
January 23, 2026 17:24 ET | Source: Czechoslovak Group A.S.

CZECHOSLOVAK GROUP announces full exercise of Over-Allotment Option in connection with its Initial Public Offering on Euronext Amsterdam

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE PUBLICATION,...